Supplemental calcium intake in the aging individual: implications on skeletal and cardiovascular health.


Journal

Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 31 12 2018
accepted: 11 02 2019
pubmed: 28 3 2019
medline: 19 7 2019
entrez: 28 3 2019
Statut: ppublish

Résumé

Adequate calcium intake during childhood is necessary to achieve optimal peak bone mass and this has the potential by increasing bone reserves, to modulate the rate of age-associated bone loss. However, data regarding the efficacy of calcium obtained either through the diet or in the form of medicinal supplementation, for prevention of bone loss and osteoporotic fractures in the elderly is conflicting. Calcium alone is unlikely to be of benefit for this purpose though the co-administration of calcium and vitamin D may have modest fracture risk benefits. Supplemental calcium with or without vitamin D has recently come into the spotlight after the publication of the findings from a controversial randomized controlled trial that associated calcium supplementation with an increased risk of myocardial infarction. Since then, multiple studies have explored this potential link. The data remains conflicting and the potential mechanistic link if any exists, remains elusive. This review examines the relationship between supplemental calcium intake and skeletal and cardiovascular health in the aging individual through an appraisal of studies done on the subject in the last three decades. It also briefly details some of the studies evaluating fractional absorption of calcium in the elderly and the rationale behind the current recommended dietary allowances of calcium.

Identifiants

pubmed: 30915723
doi: 10.1007/s40520-019-01150-5
pii: 10.1007/s40520-019-01150-5
doi:

Substances chimiques

Calcium, Dietary 0
Vitamin D 1406-16-2

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

765-781

Auteurs

Manju Chandran (M)

Osteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital, 20 College Road, 169856, Academia, Singapore. manju.chandran@singhealth.com.

Donovan Tay (D)

Department of Medicine, Sengkang General Hospital, Singapore, Singapore.

Ambrish Mithal (A)

Division of Endocrinology and Diabetes, Medanta-The Medicity, Gurgaon, New Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH